» Articles » PMID: 19252486

BMP6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism

Overview
Journal Nat Genet
Specialty Genetics
Date 2009 Mar 3
PMID 19252486
Citations 371
Authors
Affiliations
Soon will be listed here.
Abstract

Juvenile hemochromatosis is an iron-overload disorder caused by mutations in the genes encoding the major iron regulatory hormone hepcidin (HAMP) and hemojuvelin (HFE2). We have previously shown that hemojuvelin is a co-receptor for bone morphogenetic proteins (BMPs) and that BMP signals regulate hepcidin expression and iron metabolism. However, the endogenous BMP regulator(s) of hepcidin in vivo is unknown. Here we show that compared with soluble hemojuvelin (HJV.Fc), the homologous DRAGON.Fc is a more potent inhibitor of BMP2 or BMP4 but a less potent inhibitor of BMP6 in vitro. In vivo, HJV.Fc or a neutralizing antibody to BMP6 inhibits hepcidin expression and increases serum iron, whereas DRAGON.Fc has no effect. Notably, Bmp6-null mice have a phenotype resembling hereditary hemochromatosis, with reduced hepcidin expression and tissue iron overload. Finally, we demonstrate a physical interaction between HJV.Fc and BMP6, and we show that BMP6 increases hepcidin expression and reduces serum iron in mice. These data support a key role for BMP6 as a ligand for hemojuvelin and an endogenous regulator of hepcidin expression and iron metabolism in vivo.

Citing Articles

Green forage impacts on the DNA methylation in the ruminal wall of Italian mediterranean dairy buffaloes.

Fioriniello S, Salzano A, Bifulco G, Aiese Cigliano R, Della Ragione F, Campanile G Sci Rep. 2025; 15(1):8074.

PMID: 40057542 PMC: 11890600. DOI: 10.1038/s41598-025-91969-y.


BMP6 participates in the molecular mechanisms involved in APAP hepatotoxicity.

Maranon P, Isaza S, Rey E, Rada P, Garcia-Garcia Y, Dear J Arch Toxicol. 2025; 99(3):1187-1202.

PMID: 39827450 PMC: 11821676. DOI: 10.1007/s00204-024-03954-5.


Transcriptomic Response of the Ovarian Follicle Complex in Post-Vitellogenic Rainbow Trout to 17α,20β-Dihdroxy-4-pregnen-3-one In Vitro.

Ma H, Gao G, Palti Y, Tripathi V, Birkett J, Weber G Int J Mol Sci. 2024; 25(23).

PMID: 39684392 PMC: 11640809. DOI: 10.3390/ijms252312683.


Repulsive guidance molecules b (RGMb): molecular mechanism, function and role in diseases.

Zhang J, Jiang Y, Zhang Z, Li S, Fan H, Gu J Expert Rev Mol Med. 2024; 26:e24.

PMID: 39375839 PMC: 11488336. DOI: 10.1017/erm.2024.24.


The prodomain of bone morphogenetic protein 2 promotes dimerization and cleavage of BMP6 homodimers and BMP2/6 heterodimers.

Chauhan P, Xue Y, Kim H, Fisher A, Babitt J, Christian J J Biol Chem. 2024; 300(10):107790.

PMID: 39303917 PMC: 11735993. DOI: 10.1016/j.jbc.2024.107790.


References
1.
Nemeth E, Valore E, Territo M, Schiller G, Lichtenstein A, Ganz T . Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2002; 101(7):2461-3. DOI: 10.1182/blood-2002-10-3235. View

2.
Yu P, Hong C, Sachidanandan C, Babitt J, Deng D, Hoyng S . Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 2007; 4(1):33-41. PMC: 2727650. DOI: 10.1038/nchembio.2007.54. View

3.
Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J . Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2002; 33(1):21-2. DOI: 10.1038/ng1053. View

4.
Verga Falzacappa M, Casanovas G, Hentze M, Muckenthaler M . A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells. J Mol Med (Berl). 2008; 86(5):531-40. DOI: 10.1007/s00109-008-0313-7. View

5.
Nicolas G, Chauvet C, Viatte L, Danan J, Bigard X, Devaux I . The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002; 110(7):1037-44. PMC: 151151. DOI: 10.1172/JCI15686. View